Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FCI in Post-operative Low Grade Gliomas

NCT: NCT06294418 · COMPLETED

NCT IDNCT06294418
StatusCOMPLETED
Start Date2024-02-15
Completion2026-03-31

Brief Summary

The aim of this pilot study is to explore the utility of a new imaging technique, called Field Cycling Imaging (FCI), in postoperative low grade gliomas. The main question it aims to answer is if FCI can differentiate subtypes of low grade gliomas. Participants will have one FCI scan.

Frequently Asked Questions

What is FCI in Post-operative Low Grade Gliomas?

FCI in Post-operative Low Grade Gliomas is a clinical trial registered under NCT06294418. Current status: COMPLETED.

What is the status of NCT06294418?

The current status of NCT06294418 (FCI in Post-operative Low Grade Gliomas) is: COMPLETED.

When did FCI in Post-operative Low Grade Gliomas start?

FCI in Post-operative Low Grade Gliomas started on 2024-02-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.